U.S. Neuropathic Pain Medications Markets

 

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

This research service highlights the emerging opportunities in the U.S. neuropathic pain medications market and analyzes the current and future competitive landscape. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, pricing trends, and product analysis. The market is segmented by product class - opioids, antidepressants, topical analgesics, anticonvulsants and emerging therapies. Also included are individual revenue and patient forecasts for major products such as Neurontin, pregabalin, generic gabapentin, and ruboxistaurin.

Table of Contents

U.S. Neuropathic Pain Medications Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Neuropathic Pain Medications Markets, Total MarketOverviewScope and SegmentationResearch MethodologyIntroductionMarket and Technology TrendsNeuropathic Pain SyndromesDiabetic NeuropathyPostherpetic NeuralgiaHIV NeuropathyTrigeminal NeuralgiaTreatment OptionsDiabetic Neuropathic PainPostherpetic NeuralgiaHIV-associated Neuropathic PainTrigeminal NeuralgiaMarket DynamicsDemand AnalysisPatient ForecastsRevenue ForecastsFactors Affecting Market GrowthIndustry Issues and ChallengesCompetitive LandscapeCompetitive StructurePipeline AnalysisMarket Share AnalysisFrost & Sullivan AwardsCompany of the Year AwardTechnology Innovation AwardProduct Differentiation Leadership AwardIndustry Innovation and Advancement of the Year AwardU.S. Neuropathic Pain Medications Markets, Opioids MarketSegment HighlightsSegment HighlightsOverviewIntroductionAnalysisSegment IssuesMarket Forecasts and TrendsPatient ForecastsPricing TrendsRevenue ForecastsProduct AnalysisCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Neuropathic Pain Medications Markets, Antidepressants MarketSegment HighlightsSegment HighlightsOverviewIntroductionAnalysisSegment IssuesMarket Forecasts and TrendsPatient ForecastsPricing TrendsRevenue ForecastsProduct AnalysisCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Neuropathic Pain Medications Markets, Topical Analgesics MarketSegment HighlightsSegment HighlightsOverviewIntroductionAnalysisSegment IssuesMarket Forecasts and TrendsPatient ForecastsPricing TrendsRevenue ForecastsProduct AnalysisCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Neuropathic Pain Medications Markets, Anticonvulsants MarketSegment HighlightsSegment HighlightsOverviewIntroductionAnalysisSegment IssuesMarket Forecasts and TrendsPatient ForecastsPricing TrendsRevenue ForecastsProduct AnalysisCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Neuropathic Pain Medications Markets, Emerging Therapies MarketSegment HighlightsSegment HighlightsOverviewIntroductionAnalysisSegment IssuesMarket Forecasts and TrendsPatient ForecastsRevenue ForecastsProduct AnalysisU.S. Neuropathic Pain Medications Markets, AppendixDecision Support DatabaseDiabetesDiabetic NeuropathyHIV/AIDSShinglesNeurologists




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 20-Nov-17

Region : North America

Release Date : 17-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.